Journal article

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

MA Kamm, GR Lichtenstein, WJ Sandborn, S Schreiber, K Lees, K Barrett, R Joseph

Gut | BMJ PUBLISHING GROUP | Published : 2008

DOI: 10.1136/gut.2007.138248

Citation metrics

120Web of Science
145Scopus

Keywords

Colitis, Ulcerative
Gastroenterology
Sulfasalazine
Anti-Inflammatory Agents, Non-Steroidal
Recurrence
Patient Compliance
Life Sciences & Biomedicine
Colorectal-Cancer
Gastroenterology & Hepatology
Remission Induction
Drug Administration Schedule
Therapy
Humans
Quality-Of-Life
Mesalamine
Olsalazine
Chemistry, Pharmaceutical
Science & Technology
Severity of Illness Index
Release
Male
Adult
Middle Aged
Efficacy
Intestinal Mucosa
Inflammatory-Bowel-Disease
Treatment Outcome
Delayed-Action Preparations
Female